169 Results

People

  1. Kris
    Kris
  2. Miller
    Miller
  3. Riely
    Riely
  4. Rusch
    Rusch
  5. Krug
    Krug
  6. Azzoli
    Azzoli
  7. Heelan
    Heelan
  8. Tyson
    Tyson
  9. Rizvi
    Rizvi
  10. Gralla
    Gralla

Groups

  1. Department of Medicine (169)
  2. Solid Tumor Oncology Division (169)
  3. Thoracic Oncology (169)
  4. Epidemiology and Biostatistics (40)
  5. Nursing (40)
  6. Biostatistics Service (38)
  7. Surgery (38)
  8. GSK Faculty (36)
  9. Survivorship Research (32)
  10. Tow Center for Developmental Oncology (TCDO) (30)
  1. "aged"
  2. "Journal article"
  3. "Mark Kris"
Formats
  1. Journal Article (169)
Groups
  1. Department of Medicine (169)
  2. Solid Tumor Oncology Division (169)
  3. Thoracic Oncology (169)
  4. Epidemiology and Biostatistics (40)
  5. Nursing (40)
  6. Biostatistics Service (38)

More Groups

People
  1. Mark Kris (169)
  2. Vincent Miller (53)
  3. Gregory Riely (40)
  4. Valerie Rusch (32)
  5. Lee Krug (31)
  6. Christopher Azzoli (27)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2021 (1)
  4. 2020 (3)
  5. 2019 (1)
  6. 2018 (2)

More Years

Publications
  1. Clinical Cancer Research (26)
  2. Cancer (24)
  3. Journal of Thoracic Oncology (18)
  4. Journal of Clinical Oncology (15)
  5. American Journal of Clinical Oncology (8)
  6. Cancer Chemotherapy and Pharmacology (8)

More Publications

Publishers
  1. American Association for Cancer Research (28)
  2. Elsevier Inc. (27)
  3. Wiley Blackwell (26)
  4. American Society of Clinical Oncology (15)
  5. Springer (15)
  6. Lippincott Williams & Wilkins (10)

More Publishers

Results (169)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas
    Journal Article

    Paik, P. K.; Luo, J.; Ai, N.; Kim, R.; Ahn, L.; Biswas, A.; Coker, C.; Ma, W.; Wong, P.; Buonocore, D. J.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Deciphering radiological stable disease to immune checkpoint inhibitors
    Journal Article

    Luo, J.; Wu, S.; Rizvi, H.; Zhang, Q.; Egger, J. V.; Osorio, J. C.; Schoenfeld, A. J.; Plodkowski, A. J.; Ginsberg, M. S.; Callahan, M. K.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: A retrospective study
    Journal Article

    Zauderer, M. G.; Martin, A.; Egger, J.; Rizvi, H.; Offin, M.; Rimner, A.; Adusumilli, P. S.; Rusch, V. W.; Kris, M. G.; Sauter, J. L.; more...
    The Lancet Digital Health (2021)

    Fulltext@MSK | Save
  • Clinical outcomes, local–regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab
    Journal Article

    Offin, M.; Shaverdian, N.; Rimner, A.; Lobaugh, S.; Shepherd, A. F.; Simone, C. B. 2nd; Gelblum, D. Y.; Wu, A. J.; Lee, N.; Kris, M. G.; more...
    Radiotherapy and Oncology (2020)

    Fulltext@MSK | Save
  • Novel germline mutations in DNA damage repair in patients with malignant pleural mesotheliomas
    Journal Article

    Guo, R.; DuBoff, M.; Jayakumaran, G.; Kris, M. G.; Ladanyi, M.; Robson, M. E.; Mandelker, D.; Zauderer, M. G.
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save
  • Complete pathological response to crizotinib in a patient with ALK-rearranged lung adenocarcinoma
    Journal Article

    Mattar, M. S.; Chang, J.; Benayed, R.; Halpenny, D.; Powers, A.; Kleiner, D. E.; Drilon, A.; Kris, M. G.
    Clinical Lung Cancer (2020)

    Fulltext@MSK | Save
  • Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers
    Journal Article

    Offin, M.; Feldman, D.; Ni, A.; Myers, M. L.; Lai, W. V.; Pentsova, E.; Boire, A.; Daras, M.; Jordan, E. J.; Solit, D. B.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • Effects of co-occurring genomic alterations on outcomes in patients with KRAS-mutant non-small cell lung cancer
    Journal Article

    Arbour, K. C.; Jordan, E.; Kim, H. R.; Dienstag, J.; Yu, H. A.; Sanchez-Vega, F.; Lito, P.; Berger, M.; Solit, D. B.; Hellmann, M.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor–mutant lung cancers and brain metastases
    Journal Article

    Arbour, K. C.; Kris, M. G.; Riely, G. J.; Ni, A.; Beal, K.; Daras, M.; Hayes, S. A.; Young, R. J.; Rodriguez, C. R.; Ahn, L.; more...
    Cancer (2018)

    Fulltext@MSK | Save